Biotransformation of Betulonic Acid by the Fungus Rhizopus arrhizus CGMCC 3.868 and Antineuroinflammatory Activity of the Biotransformation Products
Kai-Nan Song,You-Jia Lu,Cheng-Jiao Chu,Yan-Ni Wu,Hui-Lian Huang,Bo-Yi Fan,Guang-Tong Chen
DOI: https://doi.org/10.1021/acs.jnatprod.1c00480
IF: 5.1
2021-09-21
Journal of Natural Products
Abstract:Biotransformation of betulonic acid (1) by Rhizopus arrhizus CGMCC 3.868 resulted in the production of 16 new (3, 5, 6, and 9–21) and five known compounds. Structures of the new compounds were established by analysis of spectroscopic data. Hydroxylation, acetylation, oxygenation, glycosylation, and addition reactions involved the C-20–C-29 double bond. Antineuroinflammatory activities of the obtained compounds in NO production were tested in lipopolysaccharides-induced BV-2 cells. Compared with the substrate betulonic acid, biotransformation products 3, 8, 9, 14, and 21 exhibited an improved inhibitory effect, with IC50 values of 10.26, 11.09, 5.38, 1.55, and 4.69 μM, lower than that of the positive control, NG-monomethyl-l-arginine.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c00480.Spectra of compounds 3, 5, 6, and 9–21 (PDF)This article has not yet been cited by other publications.
plant sciences,chemistry, medicinal,pharmacology & pharmacy